October 31, 2025

Simulations Plus, Inc. (SLP) Stock Analysis: A Hidden Gem in Healthcare with 34% Upside Potential

Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, is carving out a niche with its innovative drug discovery and development software solutions. With a market capitalization of..

LifeMD, Inc. (LFMD) Stock Analysis: Unveiling a 121.98% Potential Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) is stirring interest in the healthcare sector with its innovative approach to telehealth services. With a market capitalization of $275.02 million, LifeMD stands out in the..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Challenges with Strategic Collaborations in Molecular Diagnostics

Myriad Genetics, Inc. (NASDAQ: MYGN) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. As a molecular diagnostic testing and precision medicine company, Myriad..

Cel-Sci Corporation (CVM) Investor Outlook: Unveiling a Massive 2,611% Potential Upside in Biotechnology

Cel-Sci Corporation (NASDAQ: CVM) is capturing the attention of investors with its staggering potential upside of 2,611.07%, a figure that stands out in the high-stakes world of biotechnology. As a..

OrthoPediatrics Corp. (KIDS) Investor Outlook: Analyzing a 46.59% Potential Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, particularly within the medical devices industry, as a unique player focused on pediatric orthopedic solutions. Headquartered in Warsaw, Indiana, the..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 116% Potential Upside in Healthcare Innovation

Bioventus Inc. (NASDAQ: BVS), a key player in the medical devices sector, stands as a noteworthy investment candidate for those eyeing substantial growth potential within the healthcare industry. With its..

Neuropace, Inc. (NPCE) Stock Analysis: Unlocking a Potential 69.88% Upside in Healthcare Innovation

For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands as a compelling opportunity, especially with a notable potential upside of 69.88% based on the..

Semler Scientific, Inc. (SMLR) Stock Analysis: Unpacking the 206% Potential Upside for Investors

Semler Scientific, Inc. (NASDAQ: SMLR) is making waves in the healthcare sector, particularly in the medical devices industry. With a market capitalization of $372.73 million, this Santa Clara-based company is..

Personalis, Inc. (PSNL) Investor Outlook: Navigating a Tumultuous Market with Innovative Genomic Solutions

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly in diagnostics and research, with its cutting-edge cancer genomic tests and services. Even as the company grapples with..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Unlocking a 25% Upside with Robust Revenue Growth

For investors looking to tap into the healthcare sector’s promise, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling opportunity. This specialty pharmaceutical company is making significant strides in the development..

Precigen, Inc. (PGEN) Stock Analysis: A Biotech Gem with Over 100% Potential Upside

Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is captivating investor attention with its innovative approach to gene and cell therapy. Headquartered in Germantown, Maryland, this biopharmaceutical..

Weave Communications, Inc. (WEAV) Stock Analysis: Navigating a 74.83% Potential Upside in Healthcare Tech

Investors looking for opportunities in the health information services sector may want to consider Weave Communications, Inc. (NYSE: WEAV). With a market capitalization of $503.05 million, Weave is carving out..

MeiraGTx Holdings plc (MGTX): Investor Outlook Reveals a Potential 215% Upside

MeiraGTx Holdings plc (NASDAQ: MGTX), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its ambitious approach to genetic medicine. Specializing in innovative therapies for..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a 246.85% Potential Upside in Biotechnology

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector for its promising portfolio of therapies targeting autoimmune diseases and cancer. Based in Cambridge,..

Septerna, Inc. (SEPN) Stock Analysis: A 12.84% Upside Potential in the Biotechnology Sector

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company based in South San Francisco, California, is garnering attention for its innovative approach in addressing critical healthcare challenges. Operating within the healthcare..

Arvinas, Inc. (ARVN) Stock Analysis: Assessing an 81.27% Potential Upside in the Biotechnology Sector

Arvinas, Inc. (NASDAQ: ARVN) is a name that has been generating interest among investors, particularly in the healthcare sector, where innovation often leads to significant stock value appreciation. With a..

Trevi Therapeutics, Inc. (TRVI): Analyst Consensus Signals 84% Upside Potential

Investors eyeing the biotechnology sector may find Trevi Therapeutics, Inc. (NASDAQ: TRVI) a compelling prospect, particularly given the remarkable potential upside of 84.42% as identified by analysts. This clinical-stage biopharmaceutical..

Fortrea Holdings Inc. (FTRE) Investor Outlook: Navigating Challenges and Opportunities in the Biotechnology Sector

Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology sector, with its robust focus on providing innovative solutions for biopharmaceutical product and medical device development. As a contract..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a 98.97% Potential Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (NASDAQ: TSHA), a U.S.-based biotechnology firm, has been generating buzz in the healthcare sector with its innovative approach to gene therapies targeting monogenic diseases of the..

Valneva SE (VALN) Stock Analysis: Exploring a 45% Potential Upside in the Biotechnology Sector

Valneva SE (NASDAQ: VALN), a French biotech company, is making headlines in the healthcare sector with its strong revenue growth and promising pipeline of vaccines for infectious diseases. With a..

Search

Funds

October 31, 2025

Search

Funds

October 31, 2025

FTSE 100

Funds